Who is sponsoring NCT05146141?

NCT05146141 is sponsored by University of Liege.

What drugs are being tested in NCT05146141?

Interventions in NCT05146141: Bent-arm throw exercises.

What condition does NCT05146141 study?

NCT05146141 studies Tennis Serve Performance.

Is NCT05146141 still recruiting?

NCT05146141 is currently completed. Last updated 30 August 2022.

Last reviewed 2022-08-30 · How we verify

NCT05146141

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bent-arm Throw and Tennis Performance

Completed NA Last updated 30 August 2022

What this trial tests

NA trial testing Bent-arm throw exercises in Tennis Serve Performance in 64 participants. Completed in 1 July 2022.

Timeline

20 October 2021

Primary endpoint
29 April 2022

1 July 2022

Quick facts

Lead sponsor	University of Liege
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	64
Start date	20 October 2021
Primary completion	29 April 2022
Estimated completion	1 July 2022
Sites	1 location across Belgium

Drugs / interventions tested

Bent-arm throw exercises

Conditions studied

Tennis Serve Performance — all drugs for Tennis Serve Performance →

Sponsor

University of Liege

Who can join

Adults 9 to 12, any sex, with Tennis Serve Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to explore the relaitonship betwenn bent-arm throw and tennis serve performance. Young players (9-12 years) will be assessed at the beginning of the season and at mid-season to measure the accuracy, the speed and the gesture of tennis serve. During a mid-season, they will have to perform a bent-arm throw warm-up program 5 minutes before each training session to increase their ability to throw.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05146141 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 30 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05146141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing